Status:
UNKNOWN
Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19
Lead Sponsor:
National Institute of Cardiology, Warsaw, Poland
Conditions:
COVID
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Hospitalized patients with COVID-19 will be included in the study in centers around Poland. After the hospitalization, a short questionnaire will be completed, including pre-hospitalization diagnoses,...
Detailed Description
SARS-Cov-2 infection is characterized by a varied clinical course, from asymptomatic to severe respiratory failure in the course of pneumonia, which can be fatal. There are reports in the literature r...
Eligibility Criteria
Inclusion
- Hospitalized patients with COVID-19
Exclusion
- None
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 24 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04374110
Start Date
May 5 2020
End Date
August 24 2021
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cardiology
Warsaw, Poland